Современные малоинвазивные способы верификации диагноза у больных с опухолями лёгких
https://doi.org/10.20862/0042-4676-2015-0-3-52-57
Аннотация
Рак легкого является одной из актуальных проблем современной онкологии. Эффективность подбора химиотерапии обусловливает правильная морфологическая верификация. С учетом распространенности опухолевого процесса в большинстве случаев хирургическая операция не показана, поэтому необходимо получить материал для морфологического исследования другими способами. Данная статья посвящена со-
временным способам получения опухолевого материала на дооперационном этапе и в случаях, когда операция не показана, с целью подбора эффективной химиотерапии.
временным способам получения опухолевого материала на дооперационном этапе и в случаях, когда операция не показана, с целью подбора эффективной химиотерапии.
Ключевые слова
Об авторе
М. С. Бурдюков
ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»
Россия
к. м. н., ст. науч. сотр., доцент кафедры Российской медицинской академии последипломного образования
Россия
к. м. н., ст. науч. сотр., доцент кафедры Российской медицинской академии последипломного образования
Список литературы
1. Давыдов М.И., Аксель Е.М. Заболеваемость злокачественными новообразованиями. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2010; 21 (2, 80, прил. 1). / Davydov M.I., Aksel’ E.M. Incidence of oncologic diseases. Vestnik Rossiyskogo onkologicheskogo nauchnogo tsentra imeni N.N. Blokhina Rossiyskoy akademii meditsinskikh nauk. 2010; 21 (2, 80, suppl. 1) (in Russian).
2. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J. Clin. 2011; 61 (Is. 4): 212–36.
3. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S. Jr et al. American Society of Clinical Oncology. Treatment of unresectable non-small cell lung cancer guideline: update 2003. J. Clin. Oncol. 2004; 22: 330–53.
4. Parkin D.M., Bray F., Ferlay J. et al. Global cancer statistics, 2002. Cancer J. Clin. 2005; 55: 74–108.
5. Chansky K., Sculier J.P., Crowley J.J. et al. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J. Thorac. Oncol. 2009; 4: 792–801.
6. Howlader N., Noone A.M., Krapcho M. et al. (eds). SEER Cancer Statistics Review, 1975–2011. Bethesda, Md: National Cancer Institute; 2011.
7. Rami-Porta R., Crowley J.J., Goldstraw P. The revised TNM staging system for lung cancer. Ann. Thorac. Cardiovasc. Surg. 2009; 15 (1): 4–9.
8. Travis W.D., Brambilla E., Noguchi M. et al. International association for the study of lung cancer/ American Thoracic Society/ European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. Thorac. Oncol. 2011; 6 (2): 244–85.
9. Kerr K.M. Personalized medicine for lung cancer: new challenges for pathology. Histopathology. 2012; 60: 531–46.
10. Mazzone P., Jain P., Arroliga A.C., Matthay R.A. Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin. Chest. Med. 2002; 23 (1): 137–58.
11. Gellert A.R., Rudd R.M., Sinha G. Geddes Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax. 1982; 37 (9): 684–7.
12. Coghlin C.L., Smith L.J., Bakar S., Stewart K.N., Devereux G.S., Nicolson M.C., Kerr K.M. Quantitative analysis of tumor in bronchial biopsy specimens. J. Thorac. Oncol. 2010; 5 (4): 448–52.
13. Rivera M.P., Mehta A.C. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Am. Coll. Chest Phys. Chest. 2007; 132 (Suppl. 3): 131S–148S.
14. Bodh A., Kaushal V., Kashyap S., Gulati A. Cytohistological correlation in diagnosis of lung tumors by using fiberoptic bronchoscopy: study of 200 cases. Ind. J. Pathol. Microbiol. 2013; 56 (2): 84–8.
15. Lee N., Kim S.H., Kwon W. et al. The effects of bronchoscope diameter on the diagnostic yield of transbronchial lung biopsy of peripheral pulmonary nodules. Tuberc. Respir. Dis. (Seoul). 2014; 77 (6): 251–7.
16. Binesh F., Pirdehghan A., Mirjalili M.R., Samet M., Majomerd Z.A., Akhavan A. Comparative assessment of the diagnostic value of transbronchial lung biopsy and bronchoalveolar lavage fluid cytology in lung cancer. Asian. Pac. J. Cancer Prev. 2015; 16 (1): 201–4.
17. Cetinkaya E., Yildiz P., Altin S., Yilmaz V. Diagnostic value of transbronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest. 2004; 125 (2): 527–31.
18. Soja J., Szlubowski A., Wasowski D., Kuzdzal J., Zielin′ski M., Sladek K. Transbronchial needle aspiration as a diagnostic method of mediastinal adenopathy. Przegl. Lek. 2005; 62 (2): 102–4.
19. Simpson F.G., Arnold A.G., Purvis A., Belfield P.W., Muers M.F., Cooke N.J. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax. 1986; 41 (4): 311–7.
20. Kurimoto N., Nakamura H., Miyazawa T. Overview of endobronchial ultrasonography in chest medicine. J. Med. Ultrasound. 2009; 17: 31–43.
21. Asahina H., Yamazaki K., Onodera Y., Kikuchi E., Shinagawa N., Asano F., Nishimura M. Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest. 2005; 128 (3): 1761–5.
22. Szlubowski A., Zielin′ski M., Soja J. et al. A combined approach of endobronchial and endoscopic ultrasound guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging – a prospective trial. Eur. J. Cardiothorac. Surg. 2010; 37 (5): 1175–9.
23. Annema J.T., van Meerbeeck J.P., Rintoul R.C. et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA. 2010; 304 (20): 2245–52.
24. Silvestri G.A., Gonzalez A.V., Jantz M.A. et al. Methods for staging nonsmall cell lung cancer: Diagnosis and management of lung cancer. 3rd ed.: American College of Chest Physicians evidence-based clinical practiceguidelines. Chest. 2013; 143: e211S–50S.
25. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest. 2009; 136 (1): 260–71.
26. Goldstraw P., Crowley J., Chansky K. et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Thorac. Oncol. 2007; 2 (8): 706–14.
27. Sears D., Hajdu S.I. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol. 1987; 31 (2): 85–97.
28. Billah S., Stewart J., Staerkel G., Chen S., Gong Y., Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol. 2011; 119 (2): 111–7.
29. Schreiber G., McCrory D.C. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003; 123 (Suppl. 1): 115S–128S.
30. Klein J.S., Salomon G., Stewart E.A. 20 Transthoracic needle biopsy with a coaxially placed 20- gauge automated cutting needle: results in 122 patients. Radiology. 1996; 198 (3): 715–21.
31. Wu C.C., Maher M.M., Shepard J.A. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. Am. J. Roentgenol. 2011; 196 (6): W678–82.
32. Covey A.M., Gandhi R., Brody L.A. et al. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J. Vasc. Interv. Radiol. 2004; 15 (5): 479–83.
33. Khan M.F., Straub R., Moghaddam S.R., Maataoui A., Gurung J., Wagner T.O. et al. Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CTguided transthoracic biopsy. Eur. Radiol. 2008; 18 (7): 1356–63.
34. Saji H., Nakamura H., Tsuchida T., Tsuboi M., Kawate N., Konaka C., Kato H. The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest. 2002; 121 (5): 1521–6.
35. Ayar D., Golla B., Lee J.Y., Nath H. Needle-track metastasis after transthoracic needle biopsy. J. Thorac. Imag. 1998; 13 (1): 2–6.
36. Tomiyama N., Yasuhara Y., Nakajima Y., Adachi S., Arai Y., Kusumoto M. et al. CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur. J. Radiol. 2006; 59 (1): 60–4.
37. Bolliger C.T., Mathur P.N., Beamis J.F., Becker H.D., Cavaliere S., Colt H. et al. European Respiratory Society/American Thoracic Society ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur. Respir. J. 2002; 19 (2): 356–73.
38. Levine M.S., Weiss J.M., Harrell J.H., Cameron T.J., Moser K.M. Transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in solitary pulmonary nodules. Chest. 1988; 93 (6): 1152–5.
39. Laurent F., Latrabe V., Vergier B., Michel P. Percutaneous CT-guided biopsy of the lung: сomparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc. Intervent. Radiol. 2000; 23 (4): 266–72.
40. Beslic S., Zukic F., Milisic S. Percutaneous transthoracic CT guided biopsies of lung lesions; fine needle aspiration biopsy versus core biopsy. Radiol. Oncol. 2012; 46 (1): 19–22.
41. Da Cunha Santos G., Lai S.W., Saieg M.A., Geddie W.R., Pintilie M., Tsao M.S. et al. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype. Lung Cancer. 2012; 77 (3): 501–6.
42. Gelbman B.D., Cham M.D., Kim W., Libby D.M., Smith J.P., Port J.L. et al. Radiographic and clinical characterization of false negative results from CT-guided needle biopsies of lung nodules. J. Thorac. Oncol. 2012; 7 (5): 815–20.
43. Schreiber G., McCrory D.C. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003; 123 (Suppl. 1): 115S–128S.
44. Fassina A., Gazziero A., Zardo D., Corradin M., Aldighieri E., Rossi G.P. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J. Clin. Pathol. 2009; 62 (12): 1096–102.
45. Roberts M.E., Neville E., Berrisford R.G., Antunes G., Ali N.J. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. BTS Pleural Disease Guideline Group. Thorax. 2010; 65 (Suppl. 2): ii32–40.
46. Menzies R., Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann. Intern. Med. 1991 15; 114 (4): 271–6.
47. Boutin C., Viallat J.R., Cargnino P., Farisse P. Thoracoscopy in malignant pleural effusions. Am. Rev. Respir. Dis. 1981; 124 (5): 588–92.
48. Herth F.J. Nonsurgical staging of the mediastinum: EBUS and EUS. Semin. Respir. Crit. Care. Med. 2011; 32 (1): 62–8.
49. Lemaire A., Nikolic I., Petersen T., Haney J.C., Toloza E.M., Harpole D.H. Jr et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann. Thorac. Surg. 2006; 82 (4): 1185–9; discussion 1189–90
Рецензия
Для цитирования:
Бурдюков М.С. Современные малоинвазивные способы верификации диагноза у больных с опухолями лёгких. Вестник рентгенологии и радиологии. 2015;(3):52-57. https://doi.org/10.20862/0042-4676-2015-0-3-52-57
For citation:
Burdyukov M.S. Current minimally invasive procedures for the verification of diagnosis in patients with lung tumors. Journal of radiology and nuclear medicine. 2015;(3):52-57. (In Russ.) https://doi.org/10.20862/0042-4676-2015-0-3-52-57
Просмотров: 686
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 3.0 Непортированная
Послать статью по эл. почте 